Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (631-640 of 664) with videos related to

Pageof 67
Sort By:
Journal of Cancer Research and Clinical Oncology|January 18, 2025
Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemicVolker Arndt, Daniela Doege, Stefan Fröhling, et al.
Molecular Cancer Therapeutics|April 29, 2025
6-((1,4-naphthoquinone-2-yl)methyl)thio-glucose conjugates, a novel targeted approach for advanced prostate cancerTobias Busenbender, Dmitry N Pelageev, Jessica Hauschild, et al.
European Urology Focus|October 9, 2020
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line ChemotherapyChristian Daniel Fankhauser, Ben Tran, Manuel Pedregal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD DatabaseLindsay A Renfro, Fotios Loupakis, Richard A Adams, et al.
Nature Medicine|October 23, 2023
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trialAndreas Mackensen, John B A G Haanen, Christian Koenecke, et al.
BMC Cancer|April 16, 2025
Advancing the implementation of quality-assured oncological exercise therapy in Germany: protocol for the IMPLEMENT projectMirko Brandes, Anika Berling-Ernst, Hansjoerg Baurecht, et al.
World Journal of Urology|March 8, 2021
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2022
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemicVolker Arndt, Daniela Doege, Stefan Fröhling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system databaseQian Shi, Aimery de Gramont, Axel Grothey, et al.
Molecular Cancer|May 9, 2024
Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cellsLisa-Marie Rieckmann, Michael Spohn, Lisa Ruff, et al.
Pageof 67

Showing results (631-640 of 664) with videos related to

Sort By:
Pageof 67
Journal of Cancer Research and Clinical Oncology|January 18, 2025
Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemicVolker Arndt, Daniela Doege, Stefan Fröhling, et al.
Molecular Cancer Therapeutics|April 29, 2025
6-((1,4-naphthoquinone-2-yl)methyl)thio-glucose conjugates, a novel targeted approach for advanced prostate cancerTobias Busenbender, Dmitry N Pelageev, Jessica Hauschild, et al.
European Urology Focus|October 9, 2020
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line ChemotherapyChristian Daniel Fankhauser, Ben Tran, Manuel Pedregal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD DatabaseLindsay A Renfro, Fotios Loupakis, Richard A Adams, et al.
Nature Medicine|October 23, 2023
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trialAndreas Mackensen, John B A G Haanen, Christian Koenecke, et al.
BMC Cancer|April 16, 2025
Advancing the implementation of quality-assured oncological exercise therapy in Germany: protocol for the IMPLEMENT projectMirko Brandes, Anika Berling-Ernst, Hansjoerg Baurecht, et al.
World Journal of Urology|March 8, 2021
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2022
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemicVolker Arndt, Daniela Doege, Stefan Fröhling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system databaseQian Shi, Aimery de Gramont, Axel Grothey, et al.
Molecular Cancer|May 9, 2024
Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cellsLisa-Marie Rieckmann, Michael Spohn, Lisa Ruff, et al.
Pageof 67